The Best Place to Recover from Workplace Injury is at Work, with Peter Greaney of WorkCare

 

The average workplace injury lasts for eight days, but a lot of people who would self-manage and continue their activities at home will take the maximum time off from work, which may be more detrimental to them. If out for longer than 12 weeks, 25 percent of workers will not return. Not only are they burdened, but the business can be as well with interim costs of a new hire, lost work, etc.

On today’s podcast, MarketScale host Daniel Litwin speaks with Dr. Peter Greaney, executive chairman and chief medical officer of WorkCare, a company that builds constructive partnerships with the medical community, business clients, and their employees. Their goal is to educate the workforce about preventable conditions and safety challenges as well as overall employee health and quality of life.

Greaney had always been interested in prevention and had always been the kind of doctor to go the extra mile, reminding people to take their medicine or stop smoking. To his confusion, though, people kept coming back to him with the same problems, and eventually decided he wanted to have a more direct hand in bringing innovation to preventative rather than reactive medicine. Now he works with WorkCare in occupational medicine to keep people healthier at work, to prevent injury for the employed population, and more importantly, to get people back to work after an injury, which he says is often the overlooked and yet most important piece of the puzzle.

A lot of companies might overreact to injury, paying for an employee’s medication and giving them extensive time off. To Greaney, this is one of the worst things that can be done to encourage recovery. Not only does it cost the company a pretty penny, he says when people are out of work, a negative domino effect follows suit. Work and health are linked, and keeping people at work is fundamental to their income, their self-esteem, and depression levels.

For more information about the effects of workplace injuries and how they can be better managed, give this podcast with Dr. Greaney a listen.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More